Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
0.94
0.04 (4.76%)
At close: Aug 15, 2025, 3:58 PM
0.95
1.58%
After-hours: Aug 15, 2025, 07:26 PM EDT
Chemomab Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.87 | -2.88 | -1.98 | -0.95 | -0.7 | -0.48 | -0.65 | -0.46 | -0.5 | -1.12 | -0.86 | -1.7 | -2.68 | -3.91 | -10.64 | -18.56 | -33.01 |
PEG Ratio | 0.22 | 0.14 | 0.09 | 0.12 | -0.19 | 0.02 | 0.01 | 0.05 | -0.05 | -0.52 | -0.03 | -0.08 | 11.85 | -0.06 | -6.08 | -0.95 | 0.40 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | n/a | 2.52 | 1.69 | 1.38 | 0.82 | 0.39 | 0.59 | 0.67 | 0.63 | 1.03 | 0.64 | 0.81 | 0.96 | 1.28 | 1.93 | 3.02 | 4.08 |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | -1.7 | -2.06 | -1.95 | -2.44 | -6.53 | -5.38 | -7.39 | -14.7 | -25.98 | -48.94 | -36.03 | -173.62 |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | -1.7 | -2.06 | -1.95 | -2.44 | -6.53 | -5.42 | -7.4 | -14.75 | -27.18 | -48.95 | -36.68 | -174.03 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | n/a | 4.98 | 4.57 | 3.12 | 4.03 | 4.53 | 4.17 | 4.05 | 6.68 | 6.18 | 15.83 | 22.71 | 29.81 | 24.16 | 57.63 | 42.74 | 12.85 |
Current Ratio | n/a | 4.98 | 4.57 | 3.12 | 3.83 | 4.32 | 4.16 | 4.06 | 4.83 | 6.18 | 8.90 | 12.48 | 16.87 | 23.66 | 40.39 | 31.88 | 12.85 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | -2.05K | n/a | n/a | n/a | n/a | -320.07 | -35.09 | -13.18 | n/a | -416.76 | -37.37 | -161.35 | -343.36 |
Return on Equity | n/a | -0.22 | -0.21 | -0.36 | -0.29 | -0.2 | -0.23 | -0.36 | -0.31 | -0.23 | -0.19 | -0.12 | -0.09 | -0.08 | -0.05 | -0.04 | -0.03 |
Return on Assets | n/a | -0.17 | -0.17 | -0.25 | -0.22 | -0.16 | -0.17 | -0.28 | -0.25 | -0.19 | -0.17 | -0.11 | -0.08 | -0.08 | -0.04 | -0.04 | -0.03 |
Return on Invested Capital | n/a | -0.23 | -0.22 | -0.48 | -0.3 | -0.22 | -0.24 | -0.37 | -0.32 | -0.24 | -0.19 | -0.11 | -0.09 | -0.08 | -0.04 | -0.04 | -0.03 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |